| Literature DB >> 34741722 |
Vincenza Granata1, Lorenzo Faggioni2, Roberta Grassi3,4, Roberta Fusco5, Alfonso Reginelli6, Daniela Rega7, Nicola Maggialetti8, Duccio Buccicardi9, Barbara Frittoli10, Marco Rengo11, Chandra Bortolotto12, Roberto Prost13, Giorgia Viola Lacasella6, Marco Montella6, Eleonora Ciaghi14, Francesco Bellifemine14, Federica De Muzio15, Giulia Grazzini16, Massimo De Filippo17, Salvatore Cappabianca6, Andrea Laghi18, Roberto Grassi19,6, Luca Brunese15, Emanuele Neri2,19, Vittorio Miele19,16, Francesca Coppola20.
Abstract
BACKGROUND: Structured reporting (SR) in radiology is becoming increasingly necessary and has been recognized recently by major scientific societies. This study aims to build structured CT-based reports in colon cancer during the staging phase in order to improve communication between the radiologist, members of multidisciplinary teams and patients.Entities:
Keywords: Colon cancer; Computed tomography; Radiology report; Structured report
Mesh:
Year: 2021 PMID: 34741722 PMCID: PMC8795004 DOI: 10.1007/s11547-021-01418-9
Source DB: PubMed Journal: Radiol Med ISSN: 0033-8362 Impact factor: 3.469
Single score and sum of scores of the 15 panelists for structured report in the first round
| Panelist # | A1. Anthropometric data | A2. Personal assessments | A3. Allergies and adverse reactions | B1. Clinical information | C1. Examination data | C2. Contrast agent | C3. Study protocol | C4. Adverse Events | D1.Lesion | D2. Lymphadenopathy | D3. Distant metastasis | D4. Carcinosis | D5. Free payment | D6. Perforation | D7. TNM stage | D8. Accessory findings | Tot |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 5 | 3 | 3 | 5 | 5 | 5 | 5 | 5 | 4 | 5 | 5 | 5 | 5 | 5 | 4 | 5 | 74 |
| 2 | 2 | 2 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 3 | 72 |
| 3 | 5 | 5 | 5 | 5 | 4 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 79 |
| 4 | 5 | 3 | 5 | 5 | 5 | 5 | 5 | 5 | 4 | 5 | 4 | 5 | 5 | 5 | 5 | 5 | 76 |
| 5 | 3 | 1 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 74 |
| 6 | 3 | 1 | 4 | 5 | 5 | 5 | 4 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 2 | 3 | 67 |
| 7 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 4 | 5 | 5 | 79 |
| 8 | 5 | 5 | 5 | 4 | 4 | 4 | 4 | 4 | 5 | 4 | 5 | 4 | 5 | 5 | 5 | 4 | 72 |
| 9 | 3 | 3 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 4 | 5 | 75 |
| 10 | 1 | 4 | 1 | 3 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 69 |
| 11 | 3 | 4 | 4 | 4 | 5 | 5 | 3 | 5 | 2 | 3 | 3 | 5 | 5 | 3 | 5 | 5 | 64 |
| 12 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 80 |
| 13 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 80 |
| 14 | 5 | 5 | 5 | 5 | 5 | 5 | 3 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 78 |
| 15 | 4 | 3 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 4 | 5 | 1 | 72 |
| Mean | 3.93 | 3.60 | 4.47 | 4.73 | 4.87 | 4.93 | 4.60 | 4.93 | 4.67 | 4.80 | 4.80 | 4.93 | 5.00 | 4.73 | 4.67 | 4.40 | 74.07 |
| Std | 1.33 | 1.45 | 1.13 | 0.59 | 0.35 | 0.26 | 0.74 | 0.26 | 0.82 | 0.56 | 0.56 | 0.26 | 0.00 | 0.59 | 0.82 | 1.18 | 4.85 |
Single score and sum of scores of the 14 panelists for structured report in the second round
| Panelist # | A1. Anthropometric data | A2. Personal assessments | A3. Allergies and adverse reactions | B1. Clinical information | C1. Examination data | C2. Contrast agent | C3. Study protocol | C4. Adverse Events | D1.Lesion | D2. Lymphadenopathy | D3. Distant metastasis | D4. Carcinosis | D5. Free payment | D6. Perforation | D7. TNM stage | D8. Accessory findings | Tot |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 80 |
| 2 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 80 |
| 3 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 80 |
| 4 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 80 |
| 5 | 5 | 5 | 5 | 4 | 5 | 5 | 5 | 5 | 5 | 4 | 4 | 5 | 5 | 5 | 5 | 5 | 77 |
| 6 | 5 | 3 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 4 | 5 | 5 | 5 | 77 |
| 7 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 80 |
| 8 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 80 |
| 9 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 80 |
| 10 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 80 |
| 11 | 4 | 3 | 4 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 3 | 74 |
| 12 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 80 |
| 13 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 80 |
| 14 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 80 |
| Mean | 4.93 | 4.71 | 4.93 | 4.93 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 4.93 | 4.93 | 5.00 | 4.93 | 5.00 | 5.00 | 4.86 | 79.14 |
| STD | 0.27 | 0.73 | 0.27 | 0.27 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.27 | 0.27 | 0.00 | 0.27 | 0.00 | 0.00 | 0.53 | 1.83 |